Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al Ozonoff

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Cell Reports. Medicine|June 16, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
Science Translational Medicine|November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Identification of a multi-omics factor predictive of long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
JCI Insight|July 3, 2025
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injuryHarry Pickering, Narges Alipanah-Lechner, Ernie Chen, et al.
Communications Medicine|January 3, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Research Square|June 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitCharles Langelier, Abigail Glascock, Cole Maguire, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Cell Reports. Medicine|June 16, 2023
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patientsJoann Diray-Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
Science Translational Medicine|November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Identification of a multi-omics factor predictive of long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
JCI Insight|July 3, 2025
MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injuryHarry Pickering, Narges Alipanah-Lechner, Ernie Chen, et al.
Communications Medicine|January 3, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Pageof 26